JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Healthcare | 9.65% |
| 3 | Financials | 9.27% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Prospect Capital
PSEC
$1.15B
| $3.9M | ﹤0.01% |
650,928
+609,250
| +1,462% | +$3.51M |
|
3177
AAR Corp
AIR
$5.85B
| $3.89M | ﹤0.01% |
62,312
-281
| -0.4% | -$18K |
|
|
DESP
3178
DELISTED
Despegar.com
DESP
| $3.89M | ﹤0.01% |
410,935
+37,003
| +10% | +$286K |
|
3179
CALL
Transocean
RIG
$6.43B
| $3.88M | ﹤0.01% |
611,800
+36,000
| +6% | +$241K |
|
3180
CALL
Boston Scientific
BSX
$75.1B
| $3.88M | ﹤0.01% |
67,200
| – | – |
|
3181
CALL
Palantir
PLTR
$418B
| $3.88M | ﹤0.01% |
225,800
+150,000
| +198% | +$2.67M |
|
|
BBT
3182
Beacon Financial Corp
BBT
$2.69B
| $3.88M | ﹤0.01% |
156,133
+68,631
| +78% | +$1.48M |
|
3183
Scholastic
SCHL
$781M
| $3.86M | ﹤0.01% |
102,429
+42,146
| +70% | +$1.61M |
|
3184
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.21B
| $3.86M | ﹤0.01% |
80,183
-4,538
| -5% | -$208K |
|
3185
Alpha and Omega Semiconductor
AOSL
$921M
| $3.86M | ﹤0.01% |
148,006
+47,931
| +48% | +$1.18M |
|
3186
Methode Electronics
MEI
$608M
| $3.85M | ﹤0.01% |
169,585
+102,660
| +153% | +$2.4M |
|
3187
Community Bank
CBU
$3.46B
| $3.84M | ﹤0.01% |
73,761
-2,194
| -3% | -$98.6K |
|
3188
XPEL
XPEL
$1.38B
| $3.84M | ﹤0.01% |
71,312
-9,361
| -12% | -$503K |
|
3189
CALL
Zscaler
ZS
$29.7B
| $3.83M | ﹤0.01% |
17,300
+2,200
| +15% | +$407K |
|
3190
Capital Group International Focus Equity ETF
CGXU
$6.63B
| $3.83M | ﹤0.01% |
+160,549
| New | +$3.59M |
|
3191
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $3.83M | ﹤0.01% |
+20,000
| New | +$3.41M |
|
|
LGO
3192
Largo
LGO
$74.1M
| $3.82M | ﹤0.01% |
247,394
+246,085
| +18,799% | +$577K |
|
3193
HNI Corp
HNI
$3.53B
| $3.81M | ﹤0.01% |
91,060
+898
| +1% | +$34.2K |
|
3194
IES Holdings
IESC
$15.1B
| $3.81M | ﹤0.01% |
48,032
+5,890
| +14% | +$411K |
|
3195
Community Trust Bancorp
CTBI
$1.43B
| $3.8M | ﹤0.01% |
86,729
+17,096
| +25% | +$675K |
|
|
PXD
3196
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.8M | ﹤0.01% |
16,900
-79,200
| -82% | -$18.6M |
|
3197
PUT
Li Auto
LI
$12B
| $3.78M | ﹤0.01% |
100,900
+100,000
| +11,111% | +$3.61M |
|
3198
Globalstar
GSAT
$10.7B
| $3.78M | ﹤0.01% |
129,766
-208,851
| -62% | -$4.59M |
|
|
CBAY
3199
DELISTED
Cymabay Therapeutics
CBAY
| $3.78M | ﹤0.01% |
159,857
-202,830
| -56% | -$3.61M |
|
3200
PUT
Automatic Data Processing
ADP
$108B
| $3.77M | ﹤0.01% |
16,200
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.